IS2171B - Samsetning sem eykur hreyfanleika - Google Patents

Samsetning sem eykur hreyfanleika

Info

Publication number: IS2171B
Authority: IS; Iceland
Prior art keywords: combination; increases mobility; haematopoietic; mobility; increases
Prior art date: 2000-04-18

Application number

IS6581A

Other languages

English (en)

Other versions

IS6581A (is

Inventor

Ferro Laura

Porta Roberto

Lacobelli Massimo

Massimo Gianni Alessandro

Carlo Stella Carmelo

Original Assignee

Gentium Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-18

Filing date

2002-10-14

Publication date

2006-11-15

2002-10-14 Application filed by Gentium Spa filed Critical Gentium Spa

2002-10-14 Publication of IS6581A publication Critical patent/IS6581A/is

2006-11-15 Publication of IS2171B publication Critical patent/IS2171B/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Hematology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)

IS6581A 2000-04-18 2002-10-14 Samsetning sem eykur hreyfanleika IS2171B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00830293A EP1147777A1 (en)	2000-04-18	2000-04-18	Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en)	2000-04-18	2001-04-10	Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (2)

Publication Number	Publication Date
IS6581A IS6581A (is)	2002-10-14
IS2171B true IS2171B (is)	2006-11-15

Family

ID=8175292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6581A IS2171B (is)	2000-04-18	2002-10-14	Samsetning sem eykur hreyfanleika

Country Status (31)

Country	Link
US (1)	US20040131588A1 (is)
EP (3)	EP1147777A1 (is)
JP (1)	JP5205668B2 (is)
KR (1)	KR100849491B1 (is)
CN (1)	CN1183962C (is)
AT (2)	ATE443524T1 (is)
AU (2)	AU5832201A (is)
BG (1)	BG107203A (is)
CA (1)	CA2406179C (is)
CY (1)	CY1104971T1 (is)
CZ (1)	CZ20023426A3 (is)
DE (2)	DE60115222T2 (is)
DK (2)	DK1621207T3 (is)
EE (1)	EE200200596A (is)
ES (2)	ES2335776T3 (is)
HR (1)	HRP20020835A2 (is)
HU (1)	HUP0300560A3 (is)
IL (1)	IL152328A (is)
IS (1)	IS2171B (is)
MX (1)	MXPA02010346A (is)
NO (1)	NO20024988L (is)
NZ (1)	NZ522016A (is)
PL (1)	PL358100A1 (is)
PT (1)	PT1621207E (is)
RO (1)	RO121006B1 (is)
RU (1)	RU2248216C2 (is)
SI (1)	SI21079B (is)
SK (1)	SK14892002A3 (is)
UA (1)	UA73566C2 (is)
WO (1)	WO2001078761A2 (is)
ZA (1)	ZA200208413B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8771663B2 (en)	2000-04-18	2014-07-08	Gentium Spa	Formulation having mobilising activity
ATE513555T1 (de) *	2003-07-29	2011-07-15	Dompe Spa	Pharmazeutische kombination aus g-csf und plgf für blutstammzellen
EP1656451A2 (en)	2003-08-13	2006-05-17	Children's Hospital Medical Center	Chimeric peptides for the regulation of gtpases
WO2005017160A2 (en) *	2003-08-13	2005-02-24	Children's Hospital Medical Center	Mobilization of hematopoietic cells
EP2103689A1 (en) *	2008-03-19	2009-09-23	Gentium S.p.A.	Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) *	2008-07-17	2009-12-27	Владислав Николаевич Ласкавый	Средство для активации стволовых клеток
CN107007617A (zh)	2010-11-12	2017-08-04	真蒂奥姆责任有限公司	去纤维蛋白多核苷酸用于预防和/或治疗移植物抗宿主病(gvhd)
SG11201408481UA (en)	2012-06-22	2015-01-29	Gentium Spa	Euglobulin-based method for determining the biological activity of defibrotide
EP3026122A1 (en)	2014-11-27	2016-06-01	Gentium S.p.A.	Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) *	2016-11-14	2017-04-19	北京国泰通源技术有限公司	智能控水短节
CA3055174C (en) *	2018-01-12	2021-05-18	Cellmig Biolabs Inc.	Methods for generation of cytocapsulae and cytocapsular tubes
KR102749256B1 (ko)	2019-11-13	2025-01-03	후지필름 가부시키가이샤	가식 필름, 성형물, 및 전자 디바이스

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3899481A (en)	1970-11-03	1975-08-12	Crinos Industria Farmaco	Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
DE2154279A1 (de) *	1970-11-03	1972-05-25	Crinos Industria Farmaco	Medikamente für das fibrinolytische System
IT1043823B (it)	1970-11-03	1980-02-29	Prephar	Procedimento per l estrazione di acidi nucleici da organi animali
IT1206341B (it)	1984-02-16	1989-04-14	Crinos Industria Farmaco	Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en)	1985-05-28	1987-09-15	Ajax Magnethermic Corporation	Apparatus for overheating edges of skelp for the production of compression welded pipe
IT1190313B (it)	1986-04-17	1988-02-16	Crinos Industria Farmaco	Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
US5223609A (en)	1986-04-17	1993-06-29	Crinos Industria Farmacobiologica S.P.A.	Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1223322B (it) *	1987-10-23	1990-09-19	Crinos Industria Farmaco	Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) *	1988-08-24	1999-06-21	中外製薬株式会社	抗血栓剤
IT1231509B (it) *	1989-09-07	1991-12-07	Crinos Industria Farmaco	Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) *	1991-06-07	1993-04-06	Immunex Corporation	Method for improving autologous transplantation
US5977083A (en) *	1991-08-21	1999-11-02	Burcoglu; Arsinur	Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) *	1992-01-28	2000-03-15	松下電器産業株式会社	電動調理機
RU2136667C1 (ru) *	1995-04-18	1999-09-10	Научно-исследовательский институт фармакологии РАМН	Производные 2-меркаптобензимидазола, обладающие противоишемической, антиаритмической и противофибрилляторной активностью
JPH08127539A (ja) *	1994-10-31	1996-05-21	Ajinomoto Co Inc	ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
EP0801076A4 (en) *	1994-11-30	1999-12-15	Chugai Pharmaceutical Co Ltd	THROMBOCYTOTIC FACTOR
EP0937461B1 (en) *	1996-07-10	2005-07-06	Meiji Dairies Corporation	Use of proteins from the mk family as hematopoietic factor
AU1705599A (en) *	1997-11-26	1999-06-15	Allegheny University Of The Health Sciences	Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) *	1999-01-07	2003-06-03	Heska Corporation	Feline immunoglobulin E molecules and compositions there of

2000
- 2000-04-18 EP EP00830293A patent/EP1147777A1/en not_active Withdrawn
2001
- 2001-04-10 AT AT05108424T patent/ATE443524T1/de active
- 2001-04-10 RO ROA200201305A patent/RO121006B1/ro unknown
- 2001-04-10 PL PL01358100A patent/PL358100A1/xx not_active Application Discontinuation
- 2001-04-10 US US10/432,741 patent/US20040131588A1/en not_active Abandoned
- 2001-04-10 AU AU5832201A patent/AU5832201A/xx active Pending
- 2001-04-10 CZ CZ20023426A patent/CZ20023426A3/cs unknown
- 2001-04-10 EP EP01931582A patent/EP1276497B1/en not_active Expired - Lifetime
- 2001-04-10 IL IL152328A patent/IL152328A/en active IP Right Grant
- 2001-04-10 RU RU2002130719/15A patent/RU2248216C2/ru not_active IP Right Cessation
- 2001-04-10 AT AT01931582T patent/ATE310532T1/de active
- 2001-04-10 DE DE60115222T patent/DE60115222T2/de not_active Expired - Lifetime
- 2001-04-10 NZ NZ522016A patent/NZ522016A/en unknown
- 2001-04-10 AU AU2001258322A patent/AU2001258322B2/en not_active Ceased
- 2001-04-10 ES ES05108424T patent/ES2335776T3/es not_active Expired - Lifetime
- 2001-04-10 MX MXPA02010346A patent/MXPA02010346A/es active IP Right Grant
- 2001-04-10 SK SK1489-2002A patent/SK14892002A3/sk unknown
- 2001-04-10 HR HR20020835A patent/HRP20020835A2/xx not_active Application Discontinuation
- 2001-04-10 DK DK05108424.2T patent/DK1621207T3/da active
- 2001-04-10 DE DE60140015T patent/DE60140015D1/de not_active Expired - Lifetime
- 2001-04-10 EP EP05108424A patent/EP1621207B1/en not_active Expired - Lifetime
- 2001-04-10 WO PCT/EP2001/004105 patent/WO2001078761A2/en not_active Ceased
- 2001-04-10 HU HU0300560A patent/HUP0300560A3/hu unknown
- 2001-04-10 EE EEP200200596A patent/EE200200596A/xx unknown
- 2001-04-10 SI SI200120022A patent/SI21079B/sl not_active IP Right Cessation
- 2001-04-10 CA CA2406179A patent/CA2406179C/en not_active Expired - Fee Related
- 2001-04-10 KR KR1020027013967A patent/KR100849491B1/ko not_active Expired - Fee Related
- 2001-04-10 DK DK01931582T patent/DK1276497T3/da active
- 2001-04-10 PT PT05108424T patent/PT1621207E/pt unknown
- 2001-04-10 JP JP2001576061A patent/JP5205668B2/ja not_active Expired - Fee Related
- 2001-04-10 ES ES01931582T patent/ES2252227T3/es not_active Expired - Lifetime
- 2001-04-10 CN CNB018082025A patent/CN1183962C/zh not_active Expired - Fee Related
- 2001-10-04 UA UA2002119177A patent/UA73566C2/uk unknown
2002
- 2002-10-14 IS IS6581A patent/IS2171B/is unknown
- 2002-10-16 NO NO20024988A patent/NO20024988L/no not_active Application Discontinuation
- 2002-10-17 ZA ZA200208413A patent/ZA200208413B/en unknown
- 2002-10-17 BG BG107203A patent/BG107203A/bg unknown
2006
- 2006-02-08 CY CY20061100179T patent/CY1104971T1/el unknown

Also Published As

Publication number	Publication date
ATE310532T1 (de)	2005-12-15
EP1147777A1 (en)	2001-10-24
CN1183962C (zh)	2005-01-12
DK1276497T3 (da)	2006-03-27
EP1276497A2 (en)	2003-01-22
WO2001078761A2 (en)	2001-10-25
CA2406179A1 (en)	2001-10-25
RU2002130719A (ru)	2004-03-27
US20040131588A1 (en)	2004-07-08
IS6581A (is)	2002-10-14
CZ20023426A3 (cs)	2003-05-14
EP1276497B1 (en)	2005-11-23
EP1621207A2 (en)	2006-02-01
ES2252227T3 (es)	2006-05-16
NO20024988D0 (no)	2002-10-16
JP5205668B2 (ja)	2013-06-05
AU2001258322B2 (en)	2006-03-16
PT1621207E (pt)	2009-12-28
WO2001078761A3 (en)	2002-01-24
ES2335776T3 (es)	2010-04-05
EP1621207A3 (en)	2006-11-22
EP1621207B1 (en)	2009-09-23
CA2406179C (en)	2012-03-27
KR100849491B1 (ko)	2008-07-31
AU5832201A (en)	2001-10-30
RO121006B1 (ro)	2006-11-30
EE200200596A (et)	2004-04-15
BG107203A (bg)	2003-05-30
ATE443524T1 (de)	2009-10-15
ZA200208413B (en)	2003-10-17
NO20024988L (no)	2002-12-02
SK14892002A3 (sk)	2003-06-03
MXPA02010346A (es)	2004-09-06
HUP0300560A2 (hu)	2003-06-28
NZ522016A (en)	2004-10-29
DE60140015D1 (de)	2009-11-05
SI21079A (sl)	2003-06-30
KR20030010603A (ko)	2003-02-05
JP2004500437A (ja)	2004-01-08
CY1104971T1 (el)	2010-03-03
DE60115222T2 (de)	2006-08-10
DK1621207T3 (da)	2010-02-01
IL152328A0 (en)	2003-05-29
PL358100A1 (en)	2004-08-09
CN1434719A (zh)	2003-08-06
SI21079B (sl)	2006-08-31
UA73566C2 (en)	2005-08-15
RU2248216C2 (ru)	2005-03-20
IL152328A (en)	2009-12-24
HUP0300560A3 (en)	2005-07-28
DE60115222D1 (de)	2005-12-29
HRP20020835A2 (en)	2005-10-31

Publication	Publication Date	Title
AU2001269688A1 (en)	2002-01-14	Combination containing an antifolate and methylmalonic acid lowering agent
GB9807639D0 (en)	1998-06-10	Anti-inflammatory agents
IS2171B (is)	2006-11-15	Samsetning sem eykur hreyfanleika
TW200505900A (en)	2005-02-16	Muscarinic agonists
DE69905368D1 (en)	2003-03-20	Oxydiertes thymosin beta 4
SE9702860D0 (sv)	1997-08-05	New use
DK0774005T3 (da)	2000-05-22	Overfladeudtrykkelse af enzymer i genorienteret prodrug-terapi
MXPA03000188A (es)	2003-09-22	Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.
MXPA02002681A (es)	2003-10-14	Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
BG106057A (en)	2002-04-30	Method of enhancing the efficacy of anti-tumour agents
IL158155A0 (en)	2004-03-28	Use of erythropoietin to ameliorate chemotherapy-induced toxicity in vivo
AU2001261986A1 (en)	2001-12-03	Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
AU2002332488A8 (en)	2004-02-25	R-bambuterol, its preparation and therapeutic uses
MY122838A (en)	2006-05-31	Treating allergic and inflammatory conditions
YU79802A (sh)	2005-11-28	Formulacija sa aktivnošću mobilizacije
ATE246479T1 (de)	2003-08-15	Absorbierender artikel mit kanal
DE69513632D1 (de)	2000-01-05	Mikrogranulate enthaltend 5-nitroimidazolderivate
JPS51139004A (en)	1976-12-01	Rail with noise reducing constraction
MY136408A (en)	2008-09-30	Active substance combinations and therapies for treating abuse of alcohol
AU8716001A (en)	2002-02-18	Treatment of hepatitis c with thymosin and pegylated interferon
UA34293A (uk)	2001-02-15	Пристрій для корекції фізіологічного стану людини
IT247575Y1 (it)	2002-09-09	Perfezionamenti alle siringhe per la esecuzione della anestesiaepidurale.